tiprankstipranks
UCB SA (DE:UNC)
XETRA:UNC
Want to see DE:UNC full AI Analyst Report?

Compare UCB SA (UNC) vs. Competitors

38 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
UCB SA
€269.50
€50.48B
29.10
93.05%
6 Buy
2 Hold
0 Sell
Strong Buy
UCB SA
€269.28
€50.48B
29.10
91.22%
6 Buy
2 Hold
0 Sell
Strong Buy
AstraZeneca
14766.00 p
£229.00B
28.13
43.64%
12 Buy
2 Hold
1 Sell
Moderate Buy
GlaxoSmithKline
2131.00 p
£85.13B
12.93
58.32%
3 Buy
7 Hold
3 Sell
Hold
Hikma Pharmaceuticals
1554.00 p
£2.91B
11.21
-29.31%
2 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:UNC
UCB SA
269.50
129.44
92.42%
GB:0NZT
UCB SA
269.28
131.28
95.13%
GB:AZN
AstraZeneca
14,766.00
4,687.65
46.51%
GB:GSK
GlaxoSmithKline
2,131.00
838.04
64.82%
GB:HIK
Hikma Pharmaceuticals
1,348.00
-463.17
-25.57%
GB:INDV
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts